Citation Impact
Citing Papers
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 Standout
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
The clinical symptoms of Parkinson's disease
2016 Standout
Overview of observations from BATSE on the Compton Observatory
1993 StandoutNobel
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Glutamate receptor ion channels
2005 Standout
The role of cytoreductive nephrectomy in the era of molecular targeted therapy
2009
Parkinson disease
2017 Standout
Mechanisms of type-I- and type-II-interferon-mediated signalling
2005 Standout
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial
2004
Monitoring of protein conformation by high-performance size-exclusion liquid chromatography and scanning diode array second-derivative UV absorption spectroscopy
1991
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Parkinson's disease
2021 Standout
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
2013
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Medroxyprogesterone, interferon alfa‐2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis
2007
Renal cell carcinoma: Current status and future prospects
2005
Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders
2011
Adjuvant Treatment for Resected Renal Cell Carcinoma: Are All Strategies Equally Negative? Potential Implications for Trial Design With Targeted Agents
2013
Renal cell carcinoma
2009
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease
2010
Instability, stabilization, and formulation of liquid protein pharmaceuticals
1999 Standout
Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease
2011
Premotor Parkinson's disease: Concepts and definitions
2012
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
2007 StandoutNature
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease
2013
Screening for acquired cystic kidney disease: A decision analytic perspective
1995
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP
2013
Modulators of coagulation. A critical appraisal of their role in sepsis
1992
Immunotherapeutic Strategies for High-Risk Bladder Cancer
2007 StandoutNobel
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre Experience
2007
Epithelial cytokine responses and mucosal cytokine networks
1995
Parkinson's disease
2015 Standout
Radical perineal prostatectomy in obese patients
2003
Photodynamic therapy and anti-tumour immunity
2006 Standout
How regulatory T cells work
2008 Standout
Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and Future
2013
Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998
2007 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Non-motor features of Parkinson disease
2017 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Disseminated Intravascular Coagulation
1999 Standout
Autocrine secretion and the physiological concentration of cytokines
1996
Interferons: mechanisms of action and clinical applications
2003
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Renal cell carcinoma
2017 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma
2007
Engraftment syndrome following hematopoietic stem cell transplantation
2001
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Degradation of Ornithine Decarboxylase in Reticulocyte Lysate Is ATP-dependent but Ubiquitin-independent
1989 StandoutNobel
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 Standout
Difluoromethylornithine enhances inhibition of melanoma cell growth in soft agar by dexamethasone, clone a interferon and retinoic acid
1986
Dr William Coley and tumour regression: a place in history or in the future
2003
The Concept of Prodromal Parkinson’s Disease
2015
Pharmacological Treatment of Parkinson Disease
2014
Urologic Approaches to Metastatic Renal Cell Carcinoma
2001
SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
2000
Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease
2012
Macromolecular association of ADP-ribosyltransferase and its correlation with enzymic activity
1990
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Effect of Cytokine Therapy on Survival for Patients With Advanced Renal Cell Carcinoma
2000
Clinical Criteria for the Diagnosis of Parkinson’s Disease
2010
Common themes in microbial pathogenicity revisited
1997 Standout
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Prostatic Acid Phosphatase: Its Current Clinical Status
1987
The Glutamate Receptor Ion Channels
1999 Standout
Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder Cancer
1997
The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth
2009 Standout
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
1999 Standout
Renal cell carcinoma: recent progress and future directions.
1997
Possible Link Between Toxoplasma Gondii and the Anosmia Associated With Neurodegenerative Diseases
2014
Immunotherapy for metastatic renal cell carcinoma
2007
Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapy
1995
Polyamines in food and their consequences for food quality and human health
1995 Standout
Degradation of Ornithine Decarboxylase by the Mammalian and Yeast 26S Proteasome Complexes Requires all the Components of the Protease
1995 StandoutNobel
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
1999 Standout
Metastatic Renal Cell Carcinoma: Many Treatment Options, One Patient
2009
Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction
2010
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
1997
Metastatic Renal Cell Cancer and Radical Nephrectomy: Identification of Prognostic Factors and Patient Survival
1988
Arginine metabolism: nitric oxide and beyond
1998 Standout
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
Impact of obesity on clinical outcomes in robotic prostatectomy
2005 StandoutNobel
Recent advances in the biochemistry of polyamines in eukaryotes
1986 Standout
Works of Jonathan Fleischmann being referenced
Interleukin-2 self-association
1988
Prevalence of smell loss in Parkinson's disease – A multicenter study
2009
Combined laparoscopic pelvic lymph node dissection and modified belt radical perineal prostatectomy for localized prostatic adenocarcinoma
1994
Urinary interleukins in patients receiving intravesical bacillus calmette-guerin therapy for superficial bladder cancer
1989
Intracavernous Pressure Responses to Physical and Electrical Stimulation of the Cavernous Nerve in Rats
1998
Fibronectin Expression on Surgical Specimens Correlated with the Response to Intravesical Bacillus Calmette-Guerin Therapy
1993
Cytoreductive Surgery for Stage IV Renal Cell Carcinoma
1995
Diagnostic approaches to the renal mass.
1989
Interleukin-2 Immunotherapy Followed by Resection of Residual Renal Cell Carcinoma
1991
Phase III Study of Interferon Alfa-NL as Adjuvant Treatment for Resectable Renal Cell Carcinoma: An Eastern Cooperative Oncology Group/Intergroup Trial
2003
Lack of Value of Radioimmunoassay for Prostatic Acid Phosphatase as a Screening Test for Prostatic Cancer in Patients with Obstructive Prostatic Hyperplasia
1983
Fibrinolysis, thrombocytopenia, and coagulation abnormalities complicating high-dose interleukin-2 immunotherapy.
1991
Renal Cell Carcinoma and the Clonogenic Assay
1983
Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
1984